Does LEUPROLIDE Cause Injection site mass? 1,359 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,359 reports of Injection site mass have been filed in association with LEUPROLIDE (Fensolvi). This represents 1.9% of all adverse event reports for LEUPROLIDE.
1,359
Reports of Injection site mass with LEUPROLIDE
1.9%
of all LEUPROLIDE reports
42
Deaths
101
Hospitalizations
How Dangerous Is Injection site mass From LEUPROLIDE?
Of the 1,359 reports, 42 (3.1%) resulted in death, 101 (7.4%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Injection site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 1,359 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
OCTREOTIDE (880)
Which LEUPROLIDE Alternatives Have Lower Injection site mass Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM